Enhanced control of an outbreak of Mycoplasma pneumoniae pneumonia with azithromycin prophylaxis

The Journal of Infectious Diseases
J D KlausnerD J Vugia

Abstract

There are currently no recommended epidemic-control measures for Mycoplasma pneumoniae pneumonia outbreaks in closed communities. Previous studies have suggested the usefulness of chemoprophylaxis administered to close contacts of case-patients. To evaluate the effectiveness of various epidemic-control measures during an institutional outbreak, an observational study was undertaken during a very large outbreak of M. pneumoniae pneumonia at a facility for developmentally disabled residents (n = 142 cases). Control measures evaluated included no control, standard epidemic-control measures, and targeted azithromycin prophylaxis (500 mg on day 1, 250 mg/day on days 2-5) plus standard epidemic-control measures. The combined use of azithromycin prophylaxis and standard epidemic-control measures was associated with a significant reduction in the secondary attack rate. This study suggests that the addition of antibiotic prophylaxis to standard epidemic-control measures can be useful during institutional outbreaks of M. pneumoniae pneumonia.

Citations

Nov 30, 2000·Current Infectious Disease Reports·R L Atmar
Dec 10, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D R FeikinM S Cetron
Apr 20, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Igor A GuchevOleg I Klochkov
May 16, 2012·Antimicrobial Agents and Chemotherapy·Yong WangHongbin Song
Jul 23, 2008·Antimicrobial Agents and Chemotherapy·Bernard J WolffJonas M Winchell
Oct 19, 2004·Clinical Microbiology Reviews·Ken B Waites, Deborah F Talkington
Jul 11, 2008·Journal of Clinical Microbiology·Jonas M WinchellBarry S Fields
Feb 27, 2003·Emerging Infectious Diseases·Lauren Ancel MeyersStephanie Schrag
May 6, 2016·Frontiers in Microbiology·Gretchen L ParrottJiro Fujita
Mar 8, 2019·Journal of Clinical Laboratory Analysis·Chong HuangXu-Guang Guo
Apr 30, 2002·Current Opinion in Infectious Diseases·M R Hammerschlag
Feb 7, 2018·Frontiers in Public Health·Michael GdalevichJacob Moran-Gilad

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
G C GrayJ D Connor
© 2021 Meta ULC. All rights reserved